UnknownNot Applicable

Drainage or Pericardiocentesis (DROP) Alone for Recurrent Non-malignant Pericardial Effusions Requiring Intervention

Italy122 participantsStarted 2011-12

Plain-language summary

The DROP study is a prospective, multi center, randomized, open-label trial to test the efficacy and safety of extended catheter pericardial drainage in patients with non-malignant pericardial effusions.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * adult patients * pericardial effusion requiring pericardiocentesis * non-malignant etiology Exclusion Criteria: * known neoplastic etiology * known bacterial etiology

What they're measuring

Recurrent pericardial effusion

Timeframe: 12 months

Need for repeated pericardiocentesis

Timeframe: 12 months

Need for cardiac surgery

Timeframe: 12 months

Trial details

NCT IDNCT01665495

SponsorMaria Vittoria Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-12

Contact for this trial

Massimo Imazio, MD FESC

+390114393391 massimo_imazio@yahoo.it

View on ClinicalTrials.gov More Pericardial Effusion trials